DK414780A - Fremgangsmaade til fremstilling af (6r,7r)-7-( (z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamido)-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat - Google Patents

Fremgangsmaade til fremstilling af (6r,7r)-7-( (z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamido)-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat

Info

Publication number
DK414780A
DK414780A DK414780A DK414780A DK414780A DK 414780 A DK414780 A DK 414780A DK 414780 A DK414780 A DK 414780A DK 414780 A DK414780 A DK 414780A DK 414780 A DK414780 A DK 414780A
Authority
DK
Denmark
Prior art keywords
aminotiazol
carboxyprop
ceph
oxyimino
acetamido
Prior art date
Application number
DK414780A
Other languages
English (en)
Other versions
DK155525C (da
DK155525B (da
Inventor
A C Brodie
L A Wetherill
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK414780A publication Critical patent/DK414780A/da
Publication of DK155525B publication Critical patent/DK155525B/da
Application granted granted Critical
Publication of DK155525C publication Critical patent/DK155525C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK414780A 1979-10-02 1980-10-01 Fremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat DK155525C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7934204 1979-10-02
GB7934204 1979-10-02

Publications (3)

Publication Number Publication Date
DK414780A true DK414780A (da) 1981-04-03
DK155525B DK155525B (da) 1989-04-17
DK155525C DK155525C (da) 1989-09-04

Family

ID=10508246

Family Applications (1)

Application Number Title Priority Date Filing Date
DK414780A DK155525C (da) 1979-10-02 1980-10-01 Fremgangsmaade til fremstilling af (6r,7r)-7-oe(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamidoaa-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat

Country Status (36)

Country Link
US (1) US4329453A (da)
JP (1) JPS5657791A (da)
KR (1) KR840001776B1 (da)
AT (1) AT368161B (da)
AU (1) AU539519B2 (da)
BE (1) BE885489A (da)
BG (1) BG33586A3 (da)
CA (1) CA1142919A (da)
CH (1) CH645118A5 (da)
CS (1) CS214721B2 (da)
CY (1) CY1338A (da)
DD (1) DD153376A5 (da)
DE (1) DE3037102C2 (da)
DK (1) DK155525C (da)
EC (1) ECSP941099A (da)
ES (1) ES8106908A1 (da)
FI (1) FI71157C (da)
FR (1) FR2466467A1 (da)
GB (1) GB2063871B (da)
GR (1) GR69123B (da)
HK (1) HK78686A (da)
HU (1) HU184835B (da)
IT (1) IT1144006B (da)
KE (1) KE3641A (da)
MX (1) MX6545E (da)
MY (1) MY8500315A (da)
NL (1) NL190329C (da)
NO (1) NO156246C (da)
PL (1) PL126606B1 (da)
PT (1) PT71860B (da)
RO (1) RO82721B (da)
SE (1) SE449614B (da)
SU (1) SU942599A3 (da)
UA (1) UA7208A1 (da)
YU (1) YU42357B (da)
ZA (1) ZA806081B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
US4394503A (en) 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
JPS58198489A (ja) * 1982-05-14 1983-11-18 Meiji Seika Kaisha Ltd ７β−（２Ｄ−２−アミノ−２−カルボキシエチルチオアセトアミド）−７α−メトキシ−３−（１−メチル−１Ｈ−テトラゾ−ル−５−イル）−チオメチル−３−セフエム−４−カルボン酸ナトリウム塩の七水和物及びその製造方法
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
EP0169700B1 (en) * 1984-07-23 1990-05-16 Eli Lilly And Company Improved pharmaceutical formulations for ceftazidime
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
CA1239389A (en) * 1984-11-08 1988-07-19 Melvin G. Pleiss, Jr. Crystallization process
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
JP2533151B2 (ja) * 1987-02-02 1996-09-11 イーライ・リリー・アンド・カンパニー 抗生物質製造の改良法
EP0321562B1 (en) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
WO1988010262A1 (fr) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Compose cristallin de cephalosporine
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
CN1328281C (zh) * 2004-11-16 2007-07-25 广州白云山制药股份有限公司 头孢他啶的纯化方法
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物
CN102875576A (zh) * 2012-10-31 2013-01-16 苏州致君万庆药业有限公司 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法
CN104876949A (zh) * 2015-05-28 2015-09-02 浙江长典医药有限公司 一种小儿用头孢他啶化合物实体及其制剂
CN106420658A (zh) * 2016-09-23 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢他啶胶囊
CN109111467A (zh) * 2017-06-22 2019-01-01 宁应 一种51/4水头孢他啶化合物及其药物组合物制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato

Also Published As

Publication number Publication date
YU42357B (en) 1988-08-31
ECSP941099A (es) 1995-01-16
PL126606B1 (en) 1983-08-31
DD153376A5 (de) 1982-01-06
HK78686A (en) 1986-10-24
FI71157B (fi) 1986-08-14
KR840001776B1 (ko) 1984-10-19
AU6288280A (en) 1981-04-09
SE8006861L (sv) 1981-04-03
NL8005443A (nl) 1981-04-06
CS214721B2 (en) 1982-05-28
IT8049783A0 (it) 1980-10-01
ATA490080A (de) 1982-01-15
MY8500315A (en) 1985-12-31
DK155525C (da) 1989-09-04
KE3641A (en) 1986-07-11
RO82721A (ro) 1984-09-29
ES495534A0 (es) 1981-09-01
AT368161B (de) 1982-09-27
NO156246C (no) 1987-08-19
RO82721B (ro) 1984-10-30
PL227019A1 (da) 1981-06-05
SU942599A3 (ru) 1982-07-07
FI71157C (fi) 1986-11-24
MX6545E (es) 1985-07-10
NL190329B (nl) 1993-08-16
DE3037102A1 (de) 1981-04-23
BE885489A (fr) 1981-04-01
UA7208A1 (uk) 1995-06-30
CA1142919A (en) 1983-03-15
YU249780A (en) 1983-02-28
ES8106908A1 (es) 1981-09-01
NO802913L (no) 1981-04-03
US4329453A (en) 1982-05-11
CY1338A (en) 1987-01-16
PT71860A (en) 1980-11-01
FR2466467B1 (da) 1984-02-10
GB2063871A (en) 1981-06-10
ZA806081B (en) 1982-05-26
GR69123B (da) 1982-05-03
IT1144006B (it) 1986-10-29
AU539519B2 (en) 1984-10-04
NL190329C (nl) 1994-01-17
HU184835B (en) 1984-10-29
JPS5657791A (en) 1981-05-20
GB2063871B (en) 1983-06-02
SE449614B (sv) 1987-05-11
KR830004317A (ko) 1983-07-09
BG33586A3 (en) 1983-03-15
JPH0128036B2 (da) 1989-05-31
DE3037102C2 (de) 1986-04-10
FI803126L (fi) 1981-04-03
PT71860B (en) 1982-04-02
FR2466467A1 (fr) 1981-04-10
NO156246B (no) 1987-05-11
CH645118A5 (de) 1984-09-14
DK155525B (da) 1989-04-17

Similar Documents

Publication Publication Date Title
DK414780A (da) Fremgangsmaade til fremstilling af (6r,7r)-7-( (z)-2-(2-aminotiazol-4-yl)-2-(2-karboxyprop-2-oxyimino)-acetamido)-3-(1-pyridiniummetyl)-ceph-3-em-4-karboxylat-pentahydrat
AR229883A1 (es) Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
DK491780A (da) Fremgangsmaade til fremstilling af cephalosporansyrederivater
ES509957A0 (es) Procedimiento de obtencion de sin-isomeros de compuestos de partida de cefalosporina.
MX157171A (es) Procedimiento para preparar compuestos 1-oxa,aza-y tia-espirociclos
ES517332A0 (es) Procedimiento para preparar derivados de feniltiadiazinona.
ES514796A0 (es) Procedimiento para preparar compuestos tetrakisazoicos.
DK157580A (da) Fremgangsmaade til fremstilling af 7-(2-(2-amino4-thiazolyl)-2-( (1-carboxy-1,1-dialkyl) alkoxyimino) acetamido) cephemsulfoxider
DK158669C (da) Fremgangsmaade til fremstilling af 6beta-halogensubstituerede penicillansyrederivater.
NL7702222A (nl) Werkwijze voor de bereiding van nieuwe cefalosporineverbindingen.
ES509044A0 (es) Procedimiento para preparar derivados de fenilsulfonilurea sustituidos.
AR228869A1 (es) Procedimiento para preparar nuevos compuestos cefalosporanicos
ES517824A0 (es) Procedimiento para preparar derivados de cefalosporina.
ES511317A0 (es) Procedimiento para preparar derivados de imidazol.
ES544410A0 (es) Un procedimiento para la preparacion de dihidrobromuro de acido (6r,7r)-7-((z)-2-(2-tritilaminotiazol-4-il)-2-(2-t-butiloxicarbonil-prop-2-oximino)acetamido)-3-(1piridiniometil)-3-cefem-4-carboxilico cristalino.
ES509744A0 (es) Procedimiento para preparar derivados sustituidos de tetrahidropirimidinona.
NL8000545A (nl) Werkwijze ter bereiding van beta-lactamverbindingen.
ES517646A0 (es) Procedimiento para preparar nuevos compuestos anti-helminticos.
ES513256A0 (es) Procedimiento para preparar derivados de cefalosporina.
ES515567A0 (es) Procedimiento para preparar derivados de fenantreno.
ES515767A0 (es) Procedimiento para preparar derivados de indano.
DK382580A (da) Fremgangsmaade ved fremstilling af natriumsaltet af (6r,7r)-3-acetoxymetyyl-7-( (z(-2-(fur-2-yl)-2-metoxyimonoacetamido)-ceph-3-em-4-karboxylsyre
ES508833A0 (es) Procedimientos para preparar derivados de acido cefaloesporanico.
ATA387779A (de) Werkstoff zur pulvermetallurgischen herstellung von gegenstaenden mit hoher verschleissfestigkeit, sowie gegenstand daraus
ES504681A0 (es) Procedimiento para preparar derivados de 11- hidroxi-13 oxa-prostaglandina.

Legal Events

Date Code Title Description
PUP Patent expired